β-hexosaminidase, α-D-mannosidase, and β-mannosidase expression in serum from patients with carbohydrate-deficient glycoprotein syndrome type I

被引:15
|
作者
Beccari, T
Mancuso, F
Costanzi, E
Tassi, C
Barone, R
Fiumara, A
Orlacchio, A
Aisa, MC
Orlacchio, A
机构
[1] Univ Perugia, Dipartimento Sci Biochim & Biotecnol Mol, Sez Biochim & Biol Mol, I-06126 Perugia, Italy
[2] Univ Catania, Pediat Clin, Catania, Italy
[3] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON, Canada
关键词
CDG syndrome; hexosaminidase; alpha-D-mannosidase; beta-D-mannosidase;
D O I
10.1016/S0009-8981(00)00360-0
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
The activity of beta -hexosaminidase, determined \Nith 4-methylumbelliferyl-beta -N-acetylglucopyranoside substrate, and of beta -D-mannosidase was significantly higher in the serum of patients with carbohydrate-deficient glycoprotein (CDG) syndrome type IA (phosphomannomutase deficiency) than in controls. No significant differences were observed in the activity of beta -hexosaminidase, determined using 4-methylumbelliferyl-beta -N-acetylglucopyranoside-6-sulphate as substrate, and the activity of alpha -D-mannosidase. Using DEAE-cellulose chromatography, a greater amount of hexosaminidase B than hexosaminidase A was detected in CDG serum. In CDG serum, hexosaminidase A was eluted in a more basic position in the salt gradient. An isoenzyme of alpha -D-mannosidase and beta -D-mannosidase was identified in control and CDG sera. alpha -D-Mannosidase isoenzyme was eluted in a slightly more basic position in CDG serum than in control serum, whereas beta -D-mannosidase isoenzyme was eluted in the same position. (C) 2000 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:125 / 132
页数:8
相关论文
共 50 条
  • [1] Increased expression of β-hexosaminidase α chain in cultured skin fibroblasts from patients with carbohydrate-deficient glycoprotein syndrome type I
    Ichisaka, S
    Ohno, K
    Yuasa, I
    Nanba, E
    Sakuraba, H
    Suzuki, Y
    BRAIN & DEVELOPMENT, 1998, 20 (05): : 302 - 306
  • [2] Immunoglobulin levels in patients with carbohydrate-deficient glycoprotein syndrome type I
    Bjorklund, JEM
    Stibler, H
    Kristiansson, B
    Johansson, SGO
    Magnusson, CGM
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1997, 114 (02) : 116 - 119
  • [3] α-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis
    Orlacchio, A
    Bernardi, G
    Orlacchio, A
    Emiliani, C
    JOURNAL OF NEUROLOGY, 2001, 248 (12) : 1090 - 1092
  • [4] α-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis
    Antonio Orlacchio
    Giorgio Bernardi
    Aldo Orlacchio
    Carla Emiliani
    Journal of Neurology, 2001, 248 : 1090 - 1092
  • [5] Hyperglycinaemia in a child with carbohydrate-deficient glycoprotein syndrome type I
    Subhedar, NV
    Isherwood, DM
    Davidson, DC
    JOURNAL OF INHERITED METABOLIC DISEASE, 1996, 19 (06) : 796 - 797
  • [6] Anesthesia considerations in carbohydrate-deficient glycoprotein syndrome type I
    Meaudre, E
    Meyrieux, V
    Suprano, I
    Camboulives, J
    Paut, O
    PEDIATRIC ANESTHESIA, 2005, 15 (10) : 905 - 906
  • [7] Haemostatic studies in carbohydrate-deficient glycoprotein syndrome type I
    Fiumara, A
    Barone, R
    Buttitta, P
    Musso, R
    Pavone, L
    Nigro, F
    Jaeken, J
    THROMBOSIS AND HAEMOSTASIS, 1996, 76 (04) : 502 - 504
  • [8] Erratum to: α-D-mannosidase properties in serum of patients with amyotrophic lateral sclerosis
    Antonio Orlacchio
    Giorgio Bernardi
    Aldo Orlacchio
    Carla Emiliani
    Journal of Neurology, 2002, 249 (4) : 494 - 495
  • [9] Carbohydrate-deficient glycoprotein syndrome type II
    Schachter, H
    Jaeken, J
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 1999, 1455 (2-3): : 179 - 192
  • [10] Carbohydrate-deficient glycoprotein syndrome type 2
    Engelhardt, H
    Staudt, M
    Hässler, A
    Holzbach, U
    Freisinger, P
    Krägeloh-Mann, I
    JOURNAL OF INHERITED METABOLIC DISEASE, 1999, 22 (02) : 192 - 193